Skip to main content
. 2019 Jun 12;2019:9605252. doi: 10.1155/2019/9605252

Table 2.

Receptors and infection models of hepatitis viruses.

HAV HBV HCV HEV
Receptor TIM-1 [48] NTCP [46] CD81, SR-BI, OCLN, CLDN1 [4952] Unknown
Cell model HAV HBV HCV HEV
PHH +[53] +[46] +[54] +[55]
HepG2 +[53] +/– +[56]
HepG2NTCP Unknown +[46] Unknown
HepaRG Unknown +[44] +[57]
Huh7 Unknown +/– +/– +[56]
Huh7NTCP Unknown +[46] +/– Unknown
Huh7.5.1 Unknown +[58, 59] Unknown
HLCZ01 Unknown +[60] +[60] Unknown
PLC/PRF5 Unknown Unknown Unknown +[61]
A549 Unknown +[61]
iPSC-derived HLC Unknown +[19, 6264] +[17, 65] +[18, 66, 67]
hESC-derived HLC Unknown +[19] +[17, 65] +[18, 66, 67]

TIM-1: T-cell immunoglobulin and mucin domain 1; NTCP: sodium taurocholate cotransporting polypeptide; CD81: cluster of differentiation 81; SR-BI: scavenger receptor class B type I; OCLN: occluding; CLDN1: claudin-1; PHH: primary human hepatocyte; iPSC: induced pluripotent stem cell; hESC: human embryonic stem cell; HLC: hepatocyte-like cell. +: permissive; +/-: barely permissive; -: not permissive.